Selank: Research Overview of a Synthetic Anxiolytic Compound
Selank: Research Overview of a Synthetic Anxiolytic Compound Selank is a synthetic heptacompound developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in the 1990s. It is an analogue of the endogenous tetracompound tuftsin (Thr-Lys-Pro-Arg), with a stabilising extension that significantly increases its half-life in vivo. Selank has been the subject of extensive preclinical and clinical research in Russia and Eastern Europe, where it has been studied primarily for it
← Back to all articles
Peptidex — Research Grade Compounds UK. All products are for laboratory and scientific research use only. Not for human consumption.